Index of /media/mhs/bmh-faculty/bsrbr-ra/research

[ICO]NameLast modifiedSizeDescription
[DIR]Parent Directory  -  
[ ]2016_Lay-Summary_Risk-of-cancer-in-participants-who-have-previously-had-cancer.pdf18-Feb-2025 10:34 171K 
[ ]2017_Lay-Summary_Responding-to-treatment-with-tocilizumab.pdf18-Feb-2025 10:34 119K 
[ ]2017_Lay-Summary_Risk-of-Lymphoma-(a-blood-cancer).pdf18-Feb-2025 10:34 144K 
[ ]2017_Lay-Summary_Risk-of-myocardial-infarction-(heart-attack).pdf18-Feb-2025 10:34 140K 
[ ]2018_Lay-Summary_Identifying-treatment-refractory-disease-in-people-with-rheumatoid-arthritis.pdf18-Feb-2025 10:34 140K 
[ ]2018_Lay-Summary_Long-term-Persistence-with-Rituximab-in-Patients-with-Rheumatoid-Arthritis.pdf18-Feb-2025 10:34 152K 
[ ]2018_Lay-Summary_Long-term-TNF-inhibitor-treatment-in-patients-with-psoriatic-arthritis.pdf18-Feb-2025 10:34 155K 
[ ]2018_Lay-Summary_Malignancy-and-mortality-PSA---Fagerli.pdf18-Feb-2025 10:34 136K 
[ ]2018_Lay-Summary_Serious-infection-risk-is-comparable-after-1-year-between-patients-with-rheumatoid-arthritis-treated-with-rituximab-or-with-a-second-TNFi-after-stopping-a-first-TNFi.pdf18-Feb-2025 10:34 188K 
[ ]2018_Lay-Summary_The-influence-of-TNF-inhibitors-on-dementia-incidence-in-patients-with-rheumatoid-arthritis.pdf18-Feb-2025 10:34 156K 
[ ]2019_Lay-summary_Moderate-disease-does-not-necessarily-mean-moderate-disability.pdf18-Feb-2025 10:34 149K 
[ ]2020_Lay-Summary_Cervical-screening-attendance.pdf18-Feb-2025 10:34 758K 
[ ]2021_Lay-Summary_demyelination.pdf18-Feb-2025 10:34 659K 
[ ]2022_Lay-Summary---JAKPOT-effectiveness-in-RA.pdf18-Feb-2025 10:34 788K 
[ ]2022_Lay-summary_BSRBR-RA-Sequential-Biologics.pdf18-Feb-2025 10:34 632K 
[IMG]2023_Abstract_infographic_Etanercept-O-v-B-in-naive-RA.png18-Feb-2025 10:34 477K 
[ ]2023_Lay-Summary---Deprivation-and-anti-TNF-in-RA.pdf18-Feb-2025 10:34 764K 
[ ]2023_Lay-Summary_originator-to-biosimilar-switching-in-RA.pdf18-Feb-2025 10:34 79K 
[ ]2023_Lay-summary_BSRBR-RA_Etanercept-O-v-B-in-naive-RA.pdf18-Feb-2025 10:34 763K 
[ ]2024_Lay-Summary_BSRBR-RA_Tocilizumab-and-weight-RA.pdf18-Feb-2025 10:34 666K 
[ ]2024_Lay-Summary_BSRBR-RA_line-therapy-and-infections-RA.pdf18-Feb-2025 10:34 852K 
[ ]2024_Lay_Summary_BSRBR-RA_EMA_and_JAKi_prescribing.pdf18-Feb-2025 10:34 229K 
[ ]BSRBR_RA_Database_Contributors_List_2024.pdf18-Feb-2025 10:34 577K 
[ ]Rpt_FAF_for_website-2017.pdf18-Feb-2025 10:34 262K 
[DIR]existingtobeupdatedandreplaced/18-Feb-2025 10:34 -